SALVESTRINI, VIOLA
 Distribuzione geografica
Continente #
NA - Nord America 3.418
AS - Asia 2.913
EU - Europa 2.105
SA - Sud America 268
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 58
OC - Oceania 36
AN - Antartide 2
Totale 8.864
Nazione #
US - Stati Uniti d'America 3.297
CN - Cina 912
RU - Federazione Russa 900
SG - Singapore 843
IT - Italia 503
HK - Hong Kong 334
KR - Corea 279
BR - Brasile 204
VN - Vietnam 168
IE - Irlanda 129
FR - Francia 126
DE - Germania 102
IN - India 88
SE - Svezia 82
BD - Bangladesh 78
FI - Finlandia 74
CA - Canada 69
GB - Regno Unito 64
ID - Indonesia 50
JO - Giordania 44
PL - Polonia 41
AU - Australia 35
AR - Argentina 28
MX - Messico 21
JP - Giappone 20
NL - Olanda 17
IQ - Iraq 16
TR - Turchia 13
NG - Nigeria 12
EC - Ecuador 11
ES - Italia 11
PK - Pakistan 11
MA - Marocco 10
VE - Venezuela 9
ZA - Sudafrica 8
BE - Belgio 7
CO - Colombia 7
UA - Ucraina 7
BJ - Benin 6
EG - Egitto 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
GR - Grecia 5
HN - Honduras 5
KE - Kenya 5
TN - Tunisia 5
TW - Taiwan 5
AT - Austria 4
AZ - Azerbaigian 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
LT - Lituania 4
PH - Filippine 4
PT - Portogallo 4
UZ - Uzbekistan 4
AL - Albania 3
CL - Cile 3
DK - Danimarca 3
EE - Estonia 3
GT - Guatemala 3
JM - Giamaica 3
LB - Libano 3
PE - Perù 3
AQ - Antartide 2
BH - Bahrain 2
CG - Congo 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AI - Anguilla 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
GP - Guadalupe 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
Totale 8.803
Città #
Santa Clara 845
Singapore 649
Ashburn 546
Hefei 358
Hong Kong 303
Seoul 279
San Jose 255
Chandler 142
Dublin 128
Los Angeles 94
Milan 79
Beijing 76
Council Bluffs 70
Munich 69
Ho Chi Minh City 64
New York 61
Moscow 58
Kent 51
Florence 50
Paris 47
Lauterbourg 44
Buffalo 43
Fairfield 43
Helsinki 37
Phoenix 35
Ann Arbor 33
Warsaw 33
Melbourne 32
Rome 31
Mumbai 30
The Dalles 30
Chicago 29
Hanoi 29
Shanghai 29
Seattle 28
Bengaluru 26
Jakarta 26
Altamura 25
São Paulo 25
Lawrence 24
Naples 23
Dallas 21
London 21
Woodbridge 20
Turku 19
Boston 18
Houston 18
Toronto 18
Lappeenranta 17
Cambridge 16
Tokyo 16
Frankfurt am Main 15
Wilmington 15
Bologna 14
Brooklyn 14
Orem 14
Princeton 14
Figino 11
West Jordan 11
Abuja 10
Chennai 9
Denver 9
Mexico City 9
Pune 9
Baghdad 8
Belo Horizonte 8
Buenos Aires 8
San Francisco 8
Shenzhen 8
Stockholm 8
Boardman 7
Brussels 7
Charlotte 7
Guangzhou 7
Malang 7
Montreal 7
Atlanta 6
Bari 6
Brescia 6
Cotonou 6
Da Nang 6
Genoa 6
Karachi 6
Manchester 6
Medford 6
Nuremberg 6
Porto Alegre 6
San Diego 6
Yubileyny 6
Zhengzhou 6
Abidjan 5
Brasília 5
Johannesburg 5
Madrid 5
Newark 5
Quito 5
Turin 5
Amman 4
Baku 4
Biên Hòa 4
Totale 5.438
Nome #
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 250
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 230
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 216
Thermal Ablation versus SBRT in liver tumours: pros and cons 201
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 199
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 198
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 196
Open-Face Masks in Radiotherapy: Enhancing Therapeutic Strategies for Head and Neck and Brain Cancer Patients—A Comprehensive Scoping Review 192
Impact of COVID-19 on workload burden of a complex radiotherapy facility 191
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 191
Artificial Intelligence in radiotherapy: state of the art and future directions 190
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 188
A critical review on oligometastatic disease: a radiation oncologist’s perspective 187
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 187
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 185
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 181
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 180
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 180
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 179
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 176
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 175
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 174
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 174
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 172
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 171
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 170
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 170
Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis 169
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 166
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 164
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 163
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 156
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 156
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 155
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 155
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 147
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 142
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 140
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 137
ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement 137
Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery 134
The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique 131
Recent advances in de-intensification of radiotherapy in elderly cancer patients 128
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 128
The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 126
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 125
Progress and Challenges in Integrating Nutritional Care into Oncology Practice: Results from a National Survey on Behalf of the NutriOnc Research Group 122
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 122
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 109
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures 107
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 106
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 106
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 105
The impact of modern radiotherapy on radiation-induced late sequelae: Focus on early-stage mediastinal classical Hodgkin Lymphoma. A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 88
Quitting smoking after head and neck squamous cell carcinoma diagnosis: a prospective study protocol 57
Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature Review 42
Upgrading your best chances: postdiagnosis smoking cessation boosts life expectancy of patients with cancer – a systematic review and meta-analysis 38
Totale 8.864
Categoria #
all - tutte 29.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022105 0 0 0 12 6 2 10 13 7 7 20 28
2022/2023542 24 84 25 20 52 120 67 45 82 3 15 5
2023/2024444 16 30 36 24 22 62 23 107 21 41 46 16
2024/20252.877 73 254 119 392 726 407 70 159 149 98 159 271
2025/20264.036 453 587 591 296 427 129 470 179 219 247 163 275
2026/2027697 135 149 247 166 0 0 0 0 0 0 0 0
Totale 8.864